结构蛋白及血管形成因子在体表海绵状静脉畸形中的表达及意义

目的：研究结构蛋白及血管形成因子（VEGF）在体表海绵状静脉畸形（cavernous venous malformation,CVM）中的表达及意义。方法：1996－2000年CVM病理样本25例，取正常中、小型静脉各12例。采用Envision法免疫组化染色观察Ⅳ型胶原、纤维连接蛋白（Fn）、层粘连蛋白（Ln）及VEGF、血管生成素－1（Ang-1）等血管形成因子的表达，半定量分析结果。结果：Ⅳ型胶原、Fn和Ln在海绵状静脉畸形与中、小静脉中的分类似，但表达量明显较少。畸形组织和小静脉VEGF表达明显强于中型静脉，小静脉Ang-1表达明显强于静脉畸形和中型静脉。结论：Ln及VEGF表达变化可能是海绵状静脉畸形形成发展的重要因素。Ang-1表达减少可能参与海绵状静脉畸形的血管塑形障碍的发生。     

The heparin-induced thrombocytopenia and thrombosis syndrome: Treatment with intraarterial urokinase and systemic platelet aggregation inhibitors

We report a case of the heparin-induced thrombocy-topenia and thrombosis syndrome presenting with acute ischemia of a lower limb. The patient was successfully treated by withdrawal of heparin products, intraarterial urokinase, and platelet anti-aggregation therapy consisting of Dextran and aspirin.     

Studies in stress-relaxation and distensibility characteristics of small skin veins in vivo by a combined photoelectric-photographic and plethysmographic technique

Summary The phenomena of stress-relaxation and capillary outward filtration were studied in the isolated rabbit ear, perfused with blood at constant flow. The volume increase, as measured by the plethysmograph, following elevation of venous outflow pressure to 20 mm Hg for 4 min was predominantly due to capillary outward filtration in the norepinephrine constricted vascular bed (0.5 g/min). With papaverine induced dilatation (0.08 mg/min) this persistent volume increase could be attributed mainly to stress-relaxation of the veins. Engorgement of venous vessels as well as capillary outward filtration led to an increase of the ear volume that is measured by the plethysmographic technique. The photographic-photoelectric measurement of venous diameter changes was used in these experiments to distinguish intravascular from extravascular volume changes. The moduli of volume elasticity were calculated for smaller and larger veins (mean diameter 0.133 mm and 0.553 mm) with norepinephrine constriction. It has been demonstrated that the smaller veins were about seven times less distensible than the larger veins.This investigation was supported by Contract F44620-71-C-0117 of the USAF School of Aerospace Medicine, European Office of Aerospace Research (OAR), U.S. Air Force and Deutsche Forschungsgemeinschaft.This work was presented in part at the 39. Tagung der Deutschen Physiologischen Gesellschaft, Erlangen, April 1972 [Pflügers Arch. Suppl.332, R 54 (1972)].     

Influence of Agonist, Shear Rate, and Perfusion Time on Nitric Oxide Inhibition of Platelet Deposition

Nitric oxide (NO) is a physiological species involved in inhibition of platelet adhesion and aggregation. A novel NO delivery device was utilized to quantitatively assess the effects of gaseous NO on platelet deposition to agonist-coated biomaterials in the presence of a platelet suspension. Platelet deposition was evaluated as a function of agonist (collagen, fibrinogen, or IgG), shear rate (250, 500, and 750 s^–1), and perfusion time (5, 7.5, and 15 min). The minimal aqueous surface NO concentrations and fluxes necessary for significant inhibition of platelet deposition were quantified. Platelet deposition was completely inhibited at a gaseous NO exposure of 0.1 ppm, irrespective of the platelet agonist, shear rate, and perfusion time. The corresponding aqueous surface NO concentration was 0.09 nM at 250 s^–1 as predicted by a validated model. Surface fluxes ranged between 0.3 and 0.6 femtomoles cm^–2 s^–1. The results of this study are useful for establishing generalized guidelines (i.e., NO flux requirements in the presence of agonists, shear rate, and perfusion time) for the design and development of suitable biomaterials incorporating NO to reduce platelet deposition. Further studies incorporating blood, rather than platelet suspensions, are required to provide a more complete assessment of the required NO flux necessary to inhibit platelet deposition. © 2000 Biomedical Engineering Society. PAC00: 8717-d, 8719Tt     

光化学诱导的血栓形成性脑缺血及其代谢改变

本文用光化学法激发大鼠局部脑血栓形成，以组织病理学、局部脑血流量、皮层水含量、三磷酸腺苷、二磷酸腺苷，一磷酸腺苷、能量负荷、肌酸及乳酸为指标，探讨局部脑血栓形成后５天ｒＣＢＦ明显增高的可能机理。结果表明，血栓形成后局部脑组织ＡＴＰ水平进行性减少（Ｐ＜０．０１）、ＡＤＰ／ＡＴＰ及ＡＭＰ／ＡＴＰ比值明显升高（Ｐ均＜０．０１），ＬＡ及脑水含量显著增加（Ｐ＜０．０１）。这些因素既是能量衰竭、无氧酵解的结果     

动脉粥样硬化并发血栓形成家兔模型的研究

目的： 建立AS并发血栓形成的动物模型，为开展急性冠脉综合症（ACS）发病机制的研究奠定一定的实验基础。 方法： 实验组20只雄性新西兰兔，高胆固醇喂养18周，建立AS性兔模型；另取5只雄性新西兰兔用普通颗粒饲料喂养作为对组照。18周末采用血管紧张素Ⅱ 30 μg/kg静脉注射诱导，24 h后重复静脉注射1次。观察两组血脂、动脉壁斑块、血栓形态和AS血栓形成模型成功率。 结果： 实验组第9、18周血清TC、LDL-C水平明显高于对照组；实验组AS模型成功率为100%，而并发血栓的形成率为60％，可见血栓形成处血管内膜被掀起及内膜的连续性中断，伴有相应节段中膜的断裂、坏死和组织脱落，血栓与斑块相邻，而对照组未见血栓形成。 结论： 血管紧张素Ⅱ可导致血流动力学异常和血管壁结构的破坏，能成功诱导AS并发血栓形成模型，为ACS发生、发展和干预提供一个方便可行的研究方法。     

Modulation of hemostatic balance with antithrombin III replacement therapy in a case of liver cirrhosis associated with recurrent venous thrombosis

Patients with liver failure can present both thrombotic and hemorragic complications because of the deficiency in coagulation factors and inhibitors (protein C and S, antithrombin III) and impairment of fibrinolytic balance. Here we report the case of a 63-year-old man with liver cirrhosis, recurrent thrombosis, and features of low-grade consumption coagulopathy, showing severe antithrombin III deficiency (about 30% of normal values). Treatment with antithrombin III (2000 U/day) and low doses of heparin (5000 U b.i.d.) was successful in modulating the coagulation system toward an antithrombotic effect. After discharge from hospital the ambulatory treatment with antithrombin III concentrates (2000 U twice a week) allowed the attainment of antithrombin III activity of about 60% and prevented the patient from recurrence of venous thrombosis.Abbreviations AT-III Antithrombin III - DIC Disseminated intravascular coagulation - TAT complexes Thrombin-antithrombin III complexes - PAI-1 Plasminogen activator inhibitor-1     

高同型半胱氨酸诱导血管内皮功能障碍促进微循环障碍和微血栓形成

目的：采用蛋氨酸灌胃复制高同型半胱氨酸血症(hyperhomocysteinemia,HHcy)致内皮功能障碍,在此基础上，联合脂多糖（lipopolysaccharide，LPS）和角叉菜胶（carrageenan，Ca）造成大鼠体内广泛微血栓形成，观察血管内皮损伤和功能障碍对大鼠体内微血栓形成的促进作用。方法: ①内皮损伤模型的建立。SD大鼠随机分为对照组（control）、内皮功能障碍组（HHcy）。HHcy组采用蛋氨酸灌胃4周复制HHcy致内皮功能障碍模型，对照组以等量纯净水灌胃。4 周后检测血浆同型半胱氨酸（homocysteine，Hcy）水平，并取大鼠胸主动脉段进行血管舒张功能检测，同时检测血浆一氧化氮（NO）和血管性假血友病因子（von Willebrand factor，vWF）水平，以评价血管内皮功能状况。②Ca/LPS诱导微血栓形成。SD大鼠随机分为对照组（control）、微血栓组（Ca/LPS）、内皮功能障碍加微血栓组（HHcy＋Ca/LPS）。Ca/LPS组大鼠腹腔注射Ca，16 h再腹腔注射LPS。注射LPS 20 h后心脏采血检测凝血功能和血小板计数，镜下观测肠系膜微循环，24 h大鼠颈动脉采血结束实验，检测血浆NO和vWF值。对照组腹腔注射等量生理盐水，检测指标同模型组。HHcy＋Ca/LPS组大鼠经蛋氨酸灌胃持续4周后，再按照上述方法注射Ca/LPS，观察内皮功能障碍对大鼠微循环障碍和微血栓形成的影响。结果： ①蛋氨酸灌胃4周导致HHcy,血浆vWF水平显著升高，NO水平降低，内皮依赖性血管舒张功能显著降低，提示血管内皮功能受损，大鼠内皮功能障碍模型复制成功。②Ca/LPS组肠系膜微循环可见广泛微血栓形成，注射LPS后20 h ，通过检测凝血指标可见血液处于高凝状态。而与之比较，HHcy＋Ca/LPS组微循环障碍进一步加强，血小板计数减少，血浆NO值降低，vWF升高；注射LPS 20 h后可见血液处于继高凝状态之后的消耗性低凝状态。结论： 蛋氨酸灌胃4周导致HHcy,诱导血管内皮功能障碍。联合Ca/ LPS 造模可建立微循环障碍和微血栓形成的动物模型，而内皮功能障碍能加速加重微循环障碍和微血栓形成。     

Direct blood-pressure measurements: risks,technological evolution and some current problems

The direct measurement of blood pressure has found widespread use in intensive care units, operating rooms, and in emergency departments. Infection, air embolism and thrombosis are some of the risks to patients associated with both the cannulation procedure and with the apparatus used in the blood-pressure measuring process. Although there is constant revision in an attempt to reduce these risks, they cannot be completely eliminated. The need for direct blood-pressure measurements and the physiological effects of air embolism and thrombosis are reviewed. Infection and problems related to the techniques used to insert the catheters are not discussed.